Ellis R - Search Results

1

Comparative safety and immunogenicity of yeast recombinant hepatitis B vaccines containing S and pre-S2 + S antigens.

Miskovsky E, Gershman K, Clements ML, Cupps T, Calandra G, Hesley T, Ioli V, Ellis R, Kniskern P, Miller W, et al. Miskovsky E, et al. Among authors: ellis r. Vaccine. 1991 May;9(5):346-50. doi: 10.1016/0264-410x(91)90062-b. Vaccine. 1991. PMID: 1872019 Clinical Trial.

2

In vitro immune responses to hepatitis B surface antigens S and preS2 during acute infection by hepatitis B virus in humans.

Cupps TR, Hoofnagle JH, Ellis RW, Miller WJ, Gerin JL, Volkman DJ, Haas-Smith SA. Cupps TR, et al. Among authors: ellis rw. J Infect Dis. 1990 Mar;161(3):412-9. doi: 10.1093/infdis/161.3.412. J Infect Dis. 1990. PMID: 2313122

3

In vitro immune responses to hepatitis B surface antigen (Pre-S2 and S) following remote infection by hepatitis B virus in humans.

Cupps TR, Hoofnagle JH, Ellis RW, Miller WJ, Seeff L, Guerrera A, Gerin JL, Haas-Smith SA. Cupps TR, et al. Among authors: ellis rw. J Clin Immunol. 1989 May;9(3):229-41. doi: 10.1007/BF00916819. J Clin Immunol. 1989. PMID: 2768432

4

In vitro T cell immune responses to the preS2 antigen of the hepatitis B virus envelope protein in preS2 + S vaccine recipients. Absence of cross-reactivity of subtypes at a major T cell recognition site.

Cupps TR, Tibbles J, Hurni WM, Miller WJ, Ellis RW, Milich D, Wetter N. Cupps TR, et al. Among authors: ellis rw. J Immunol. 1993 Sep 15;151(6):3353-60. J Immunol. 1993. PMID: 7690803

5

A candidate vaccine for hepatitis B containing the complete viral surface protein.

Kniskern PJ, Hagopian A, Burke P, Dunn N, Emini EA, Miller WJ, Yamazaki S, Ellis RW. Kniskern PJ, et al. Among authors: ellis rw. Hepatology. 1988 Jan-Feb;8(1):82-7. doi: 10.1002/hep.1840080117. Hepatology. 1988. PMID: 2448217

6

Vaccination of infants and children against hepatitis B.

West DJ, Calandra GB, Ellis RW. West DJ, et al. Among authors: ellis rw. Pediatr Clin North Am. 1990 Jun;37(3):585-601. doi: 10.1016/s0031-3955(16)36906-1. Pediatr Clin North Am. 1990. PMID: 2140881 Review.

7

Immunogenicity and safety of Haemophilus influenzae type b polysaccharide-Neisseria meningitidis conjugate vaccine in 7.5 micrograms liquid formulation: a comparison of three lots with the 15.0 micrograms lyophilized formulation. Study Group for 7.5 micrograms Liquid PedvaxHIB.

Mendelman PM, Feeley L, Bird S, Staub T, Matthews H, Del Beccaro MA, Overturf G, Lee A, Ellis R, Staub J, Szymanski S, Donnelly J, Hennessey JP, Kniskern P. Mendelman PM, et al. Among authors: ellis r. Vaccine. 1997 Apr-May;15(6-7):775-81. doi: 10.1016/s0264-410x(96)00129-6. Vaccine. 1997. PMID: 9178481 Clinical Trial.

8

Antibody assays suitable for assessing immune responses to live varicella vaccine.

Provost PJ, Krah DL, Kuter BJ, Morton DH, Schofield TL, Wasmuth EH, White CJ, Miller WJ, Ellis RW. Provost PJ, et al. Among authors: ellis rw. Vaccine. 1991 Feb;9(2):111-6. doi: 10.1016/0264-410x(91)90266-9. Vaccine. 1991. PMID: 1647574

9

Varicella vaccine (VARIVAX) in healthy children and adolescents: results from clinical trials, 1987 to 1989.

White CJ, Kuter BJ, Hildebrand CS, Isganitis KL, Matthews H, Miller WJ, Provost PJ, Ellis RW, Gerety RJ, Calandra GB. White CJ, et al. Among authors: ellis rw. Pediatrics. 1991 May;87(5):604-10. Pediatrics. 1991. PMID: 1850506

10

Production and immunological analysis of recombinant hepatitis B vaccine.

Emini EA, Ellis RW, Miller WJ, McAleer WJ, Scolnick EM, Gerety RJ. Emini EA, et al. Among authors: ellis rw. J Infect. 1986 Jul;13 Suppl A:3-9. doi: 10.1016/s0163-4453(86)92563-6. J Infect. 1986. PMID: 2427590

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,099 results

Search Page

Filters